Dr Reddys Laboratories (RDY) Non-Current Debt (2012 - 2026)

Dr Reddys Laboratories' Non-Current Debt history runs 14 years deep, the most recent figure standing at $133.5 million for Q1 2026.

• In Q1 2026, Non-Current Debt rose 46.99% year-over-year to $133.5 million; the TTM figure through Mar 2026 stood at $133.5 million (up 46.99% YoY), while the FY2026 annual figure was $130.0 million, up 41.3% from the prior year.
• Non-Current Debt was $133.5 million for Q1 2026 at Dr Reddys Laboratories, roughly flat from $133.4 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $133.5 million in Q1 2026 to a low of $15.5 million in Q1 2023.
• Historically, Non-Current Debt has averaged $79.5 million across 5 years, with a median of $82.2 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Debt slumped 79.66% in 2023, then surged 363.95% in 2024.
• A 5-year view of Non-Current Debt shows it stood at $22.5 million in 2022, then soared by 296.48% to $89.3 million in 2023, then retreated by 1.54% to $87.9 million in 2024, then soared by 51.8% to $133.4 million in 2025, then climbed by 0.06% to $133.5 million in 2026.
• The last three Non-Current Debt figures came in at $133.5 million (Q1 2026), $133.4 million (Q3 2025), and $90.8 million (Q1 2025), per Business Quant data.